Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
Grisham RN, Vergote I, Banerjee S, Drill E, Kalbacher E, Mirza MR, Romero I, Vuylsteke P, Coleman RL, Hilpert F, Oza AM, Westermann A, Oehler MK, Pignata S, Aghajanian C, Colombo N, Cibula D, Moore KN, Del Campo JM, Berger R, Marth C, Sehouli J, O'Malley DM, Churruca C, Kristensen G, Clamp A, Farley J, Iyer G, Ray-Coquard I, Monk BJ. Grisham RN, et al. Among authors: vuylsteke p. Clin Cancer Res. 2023 Oct 13;29(20):4068-4075. doi: 10.1158/1078-0432.CCR-23-0621. Clin Cancer Res. 2023. PMID: 37581616 Free PMC article.
Bibliometric analysis of cancer research outputs in Botswana between 2009 and 2021.
Koobotse MO, Zachariah M, Senabye B, Gobe I, Kadimo K, Nthontho KC, Mokomane M, Koto G, Phuthego T, Lekgetho H, Ndlovu A, Motswaledi M, Mbwinja A, Tawe L, Ramatlho P, Paganotti GM, Kyokunda L, Vuylsteke P, Grover S, Ramogola-Masire D, Kasvosve I. Koobotse MO, et al. Among authors: vuylsteke p. J Cancer Policy. 2023 Mar;35:100405. doi: 10.1016/j.jcpo.2023.100405. Epub 2023 Jan 20. J Cancer Policy. 2023. PMID: 36690157 Free PMC article. Review.
A Multi-Institutional Study of Barriers to Cervical Cancer Care in Sub-Saharan Africa.
Kambhampati A, Meghani K, Ndlovu N, Monare B, Mutimuri M, Bazzett-Matabele L, Vuylsteke P, Ketlametswe R, Ralefala T, Neugut AI, Jacobson JS, Vulpe H, Grover S. Kambhampati A, et al. Among authors: vuylsteke p. Adv Radiat Oncol. 2023 Apr 24;8(5):101257. doi: 10.1016/j.adro.2023.101257. eCollection 2023 Sep-Oct. Adv Radiat Oncol. 2023. PMID: 37408670 Free PMC article.
Advancing oncology drug therapies for sub-Saharan Africa.
Sharma K, Mayer T, Li S, Qureshi S, Farooq F, Vuylsteke P, Ralefala T, Marlink R. Sharma K, et al. Among authors: vuylsteke p. PLOS Glob Public Health. 2023 Jun 27;3(6):e0001653. doi: 10.1371/journal.pgph.0001653. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37368872 Free PMC article. Review.
Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020.
Grover S, George J, Tuli S, Lichter K, Bhatia R, Monare B, Chinniah G, Bazzett-Matabele L, Bvochora-Nsingo M, Chiyapo S, Balang D, Ralefala T, Vuylsteke P, Luckett R, Shin S, Zetola N, Ramogola-Masire D. Grover S, et al. Among authors: vuylsteke p. Gynecol Oncol Rep. 2022 Oct 26;44:101094. doi: 10.1016/j.gore.2022.101094. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36337265 Free PMC article.
Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting.
Grover S, MacDuffie E, Nsingo M, Lei X, Mehta P, Davey S, Urusaro S, Chiyapo S, Vuylsteke P, Monare B, Bazzett-Matabele L, Ralefala T, Luckett R, Ramogola-Masire D, Smith GL. Grover S, et al. Among authors: vuylsteke p. JCO Glob Oncol. 2023 Sep;9:e2200397. doi: 10.1200/GO.22.00397. JCO Glob Oncol. 2023. PMID: 37738538
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, Marme F, Schröder CP, Huober J, Duhoux FP, Vuylsteke P, Jager A, Brain E, Kuemmel S, Pápai Z, Menke-van der Houven van Oordt CW, Perjesi L, Mueller C, Brignone C, Triebel F. Wildiers H, et al. Among authors: vuylsteke p. Clin Cancer Res. 2024 Feb 1;30(3):532-541. doi: 10.1158/1078-0432.CCR-23-1173. Clin Cancer Res. 2024. PMID: 37939105 Free PMC article. Clinical Trial.
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
Meghani K, Puri P, Bazzett-Matabele L, Vuylsteke P, Luckett R, Monare B, Chiyapo S, Ketlametswe R, Ralefala TB, Bvochora-Nsingo M, Zetola N, Ramogola-Masire D, Grover S. Meghani K, et al. Among authors: vuylsteke p. Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289. Online ahead of print. Cancer. 2024. PMID: 38529676
115 results